Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares are...

Prana Biotechnology Limited (ADR) (NASDAQRAN) shares are expected to touch $3 in the short term. This short term price target has been shared by 1 analysts. However, the standard deviation of short term price estimate has been valued at 0. The target price could hit $3 on the higher end and $3 on the lower end.The information is based on average recommendation on company rating and price target for short term (6 to 12 months) .

Prana Biotechnology Limited (ADR) (NASDAQRAN) : Strong bullish mood helped the shares of Prana Biotechnology Limited (ADR) (NASDAQRAN) appreciate in value. The share price gained 0.14 points or 9.33% to close at $1.64 with 391,313 shares

Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimers disease. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company is also focusing on Huntingtons and Parkinsons diseases. Other potential applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease and age-related cataracts.